• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇化合成表面活性剂囊泡(非离子表面活性剂囊泡):用于寡核苷酸的新型载体。

PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides.

作者信息

Huang Yongzhuo, Chen Jinliang, Chen Xiaojin, Gao Jianqing, Liang Wenquan

机构信息

College of Pharmaceutical Sciences, Zhejiang University, 388 Yuhangtang Road, Hangzhou, P.R. China.

出版信息

J Mater Sci Mater Med. 2008 Feb;19(2):607-14. doi: 10.1007/s10856-007-3193-4. Epub 2007 Jul 10.

DOI:10.1007/s10856-007-3193-4
PMID:17619962
Abstract

Polyethylene glycol (PEG) modified cationic niosomes were used to improve the stability and cellular delivery of oligonucleotides (OND). PEGylated cationic niosomes, composed of DC-Chol, PEG2000-DSPE and the non-ionic surfactant-Span, offer some advantages as gene carriers. Complexes of PEGylated cationic niosomes and OND showed a neutral zeta potential with particle size about 300 nm. PEG-modification significantly decreased the binding of serum protein and prevented particle aggregation in serum. The loaded nuclear acid drug exhibited increased resistance to serum nuclease. Compared with cationic niosomes, the PEGylated niosomes showed a higher efficiency of OND cellular uptake in serum. Therefore, in terms of their stable physiochemical properties in storage and physiological environment, as well as low-cost and widely available materials, PEGylated cationic niosomes are promising drug delivery systems for improved OND potency in vivo.

摘要

聚乙二醇(PEG)修饰的阳离子脂质体被用于提高寡核苷酸(OND)的稳定性和细胞递送能力。由二油酰基磷脂酰胆碱(DC-Chol)、聚乙二醇2000-二硬脂酰基磷脂酰乙醇胺(PEG2000-DSPE)和非离子表面活性剂司盘组成的聚乙二醇化阳离子脂质体作为基因载体具有一些优势。聚乙二醇化阳离子脂质体与OND的复合物呈现中性ζ电位,粒径约为300 nm。PEG修饰显著降低了血清蛋白的结合,并防止了血清中的颗粒聚集。负载的核酸药物对血清核酸酶的抗性增强。与阳离子脂质体相比,聚乙二醇化脂质体在血清中对OND的细胞摄取效率更高。因此,就其在储存和生理环境中的稳定理化性质以及低成本和广泛可用的材料而言,聚乙二醇化阳离子脂质体是有望提高体内OND效力的药物递送系统。

相似文献

1
PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides.聚乙二醇化合成表面活性剂囊泡(非离子表面活性剂囊泡):用于寡核苷酸的新型载体。
J Mater Sci Mater Med. 2008 Feb;19(2):607-14. doi: 10.1007/s10856-007-3193-4. Epub 2007 Jul 10.
2
PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.聚乙二醇化非离子表面活性剂囊泡作为 Gambogenic 酸的药物传递系统。
Drug Deliv. 2013 Sep-Oct;20(7):277-84. doi: 10.3109/10717544.2013.836618.
3
Preparation and Evaluation of Paclitaxel-Loaded PEGylated Niosomes Composed of Sorbitan Esters.紫杉醇载药 PEG 化山梨醇酯类脂质体的制备与评价。
Biol Pharm Bull. 2023;46(10):1479-1483. doi: 10.1248/bpb.b23-00188.
4
Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles.负载亲水性化合物的聚乙二醇化脂质纳米载体的皮肤转运:脂质体、非离子表面活性剂囊泡和固体脂质纳米粒的比较研究
Biol Pharm Bull. 2016;39(8):1254-62. doi: 10.1248/bpb.b15-00981.
5
Cationic niosomes as gene carriers: preparation and cellular uptake in vitro.阳离子脂质体作为基因载体:体外制备及细胞摄取
Pharmazie. 2005 Jun;60(6):473-4.
6
Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity.隐形聚乙二醇-聚(N-羟丙基二甲基氨基乙酸)脂质体:聚乙二醇链长和粒径对脂质体表面性质、体外药物释放、吞噬摄取、体内药代动力学及抗肿瘤活性的影响
J Pharm Sci. 2006 Sep;95(9):1873-87. doi: 10.1002/jps.20491.
7
Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.转铁蛋白修饰的载羟基喜树碱聚乙二醇化非离子表面活性剂囊泡对肿瘤的高效靶向作用
J Control Release. 2009 Jan 19;133(2):96-102. doi: 10.1016/j.jconrel.2008.09.005. Epub 2008 Sep 19.
8
PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU.聚乙二醇化非离子表面活性剂囊泡介导的丹皮酚给药系统:制备、药代动力学研究及与5-氟尿嘧啶的协同抗肿瘤作用
J Liposome Res. 2017 Jun;27(2):161-170. doi: 10.1080/08982104.2016.1191021. Epub 2016 Jun 30.
9
Hydration of surfactant-modified and PEGylated cationic cholesterol-based liposomes and corresponding lipoplexes by monitoring a fluorescent probe and the dielectric relaxation time.通过监测荧光探针和介电弛豫时间研究表面活性剂修饰和聚乙二醇化阳离子胆固醇脂质体及其相应的脂质体复合物的水合作用。
Int J Pharm. 2012 May 10;427(2):372-8. doi: 10.1016/j.ijpharm.2012.02.018. Epub 2012 Feb 18.
10
Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles.聚乙二醇 - 胆固醇(Chol - PEGm)缀合物的合成及其在非离子表面活性剂囊泡物理化学表征中的应用
Colloids Surf B Biointerfaces. 2008 Jun 1;63(2):192-9. doi: 10.1016/j.colsurfb.2007.11.019. Epub 2007 Dec 8.

引用本文的文献

1
Efficient PEGylated magnetic nanoniosomes for co-delivery of artemisinin and metformin: a new frontier in chemotherapeutic efficacy and cancer therapy.高效 PEG 化磁性纳米囊泡共载青蒿素和二甲双胍:化疗疗效和癌症治疗的新前沿。
Sci Rep. 2024 Nov 9;14(1):27380. doi: 10.1038/s41598-024-78817-1.
2
Production of PEGylated Vancomycin-Loaded Niosomes by a Continuous Supercritical CO Assisted Process.通过连续超临界CO₂辅助工艺制备聚乙二醇化载万古霉素脂质体
Nanomaterials (Basel). 2024 May 13;14(10):846. doi: 10.3390/nano14100846.
3
Combinational therapy with Myc decoy oligodeoxynucleotides encapsulated in nanocarrier and X-irradiation on breast cancer cells.

本文引用的文献

1
Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization.甘露糖基化非离子表面活性剂囊泡作为口服黏膜免疫的佐剂-载体系统
J Liposome Res. 2006;16(4):331-45. doi: 10.1080/08982100600992302.
2
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.用于胰岛素递送的聚氧乙烯烷基醚脂质体的体外研究
Int J Pharm. 2007 Jan 10;328(2):130-41. doi: 10.1016/j.ijpharm.2006.08.002. Epub 2006 Aug 12.
3
Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
纳米载体包裹的 Myc 诱饵寡脱氧核苷酸与 X 射线联合治疗乳腺癌细胞。
Oncol Res. 2023 Dec 28;32(2):309-323. doi: 10.32604/or.2023.043576. eCollection 2023.
4
Polyvinyl Alcohol (PVA)-Based Nanoniosome for Enhanced in vitro Delivery and Anticancer Activity of Thymol.基于聚乙烯醇(PVA)的纳米囊泡增强百里香酚的体外递送和抗癌活性。
Int J Nanomedicine. 2023 Jun 27;18:3459-3488. doi: 10.2147/IJN.S401725. eCollection 2023.
5
Fabrication, optimization, and characterization of pH-responsive PEGylated nanoniosomes containing gingerol for enhanced treatment of breast cancer.用于增强乳腺癌治疗的含姜辣素的pH响应性聚乙二醇化纳米非离子表面活性剂囊泡的制备、优化及表征
Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3867-3886. doi: 10.1007/s00210-023-02579-2. Epub 2023 Jun 27.
6
Gene Therapy: The Next-Generation Therapeutics and Their Delivery Approaches for Neurological Disorders.基因治疗:用于神经系统疾病的下一代治疗方法及其递送途径。
Front Genome Ed. 2022 Jun 22;4:899209. doi: 10.3389/fgeed.2022.899209. eCollection 2022.
7
Preparation and Evaluation of A Novel Liposomal Nano-Formulation in Metastatic Cancer Treatment Studies.新型脂质体纳米制剂在转移性癌症治疗研究中的制备与评价
Cell J. 2019 Jul;21(2):135-142. doi: 10.22074/cellj.2019.6008. Epub 2019 Feb 20.
8
Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery.阳离子脂质体作为核酸的非病毒载体:基因递送中的挑战与机遇
Pharmaceutics. 2019 Jan 22;11(2):50. doi: 10.3390/pharmaceutics11020050.
9
Magnetic delivery of antitumor carboplatin by using PEGylated-Niosomes.使用聚乙二醇化脂质体进行抗肿瘤卡铂的磁性递送。
Daru. 2018 Sep 12;26(1):57-64. doi: 10.1007/s40199-018-0215-3.
10
Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.使用纳米药物递送系统的RNA干扰与抗癌药物的联合治疗方法。
Drug Dev Ind Pharm. 2017 Sep;43(9):1391-1401. doi: 10.1080/03639045.2017.1313861. Epub 2017 May 19.
脂质体和非离子表面活性剂囊泡增强非那雄胺的卵泡递送 1. 使用仓鼠胁腹和耳部模型的体外渗透和体内沉积研究。
Int J Pharm. 2006 Oct 12;323(1-2):1-10. doi: 10.1016/j.ijpharm.2006.05.041. Epub 2006 May 26.
4
Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.尼奥斯体作为维甲酸的载体。III. 对囊泡包裹维甲酸的体外皮肤给药研究。
Int J Pharm. 2006 Mar 27;311(1-2):11-9. doi: 10.1016/j.ijpharm.2005.11.045. Epub 2006 Jan 24.
5
Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.乙酰唑胺反相蒸发和多层非离子表面活性剂囊泡眼用载体的制备与评价
Int J Pharm. 2005 Dec 8;306(1-2):71-82. doi: 10.1016/j.ijpharm.2005.09.023. Epub 2005 Nov 2.
6
Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats.以脱水山梨醇单酯为载体的胰岛素阴道给药脂质体:大鼠实验研究
Drug Deliv. 2005 Nov-Dec;12(6):399-407. doi: 10.1080/10717540590968891.
7
Mannosylated niosomes as carrier adjuvant system for topical immunization.甘露糖基化非离子表面活性剂囊泡作为局部免疫的载体佐剂系统。
J Pharm Pharmacol. 2005 Sep;57(9):1177-84. doi: 10.1211/jpp.57.9.0012.
8
Cationic niosomes as gene carriers: preparation and cellular uptake in vitro.阳离子脂质体作为基因载体:体外制备及细胞摄取
Pharmazie. 2005 Jun;60(6):473-4.
9
Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B.基于非离子表面活性剂的囊泡(非离子脂质体)用于乙型肝炎的非侵入性局部基因免疫。
Int J Pharm. 2005 May 30;296(1-2):80-6. doi: 10.1016/j.ijpharm.2005.02.016. Epub 2005 Apr 7.
10
Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.甘露糖基化非离子表面活性剂囊泡作为用于口服抗乙型肝炎基因免疫的佐剂-载体系统
Immunol Lett. 2005 Oct 15;101(1):41-9. doi: 10.1016/j.imlet.2005.04.002. Epub 2005 Apr 25.